[Literature Library] Oral immunotherapy using partially hydrolyzed formula for cow’s milk protein allergy

This randomized controlled trial found that oral immunotherapy with hydrolyzed cow’s milk protein-based formula (pHF) may safely enhance tolerance to cow’s milk in children with cow’s milk allergy (CMPA), suggesting it may be a potential therapeutic strategy for this group.

1 min read

Save (for later)

Link to Publication: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262684/

Reference

Inuo C et al. Oral immunotherapy using partially hydrolyzed formula for cow’s milk protein allergy: A randomized, controlled trial. Int Arch Allergy Immunol.2018;177:259-268.

WYE-EM-017-JAN-19